Amuvatinib (MP-470)
Amuvatinib (MP-470, HPK 56) is a potent and multi-targeted inhibitor of c-Kit, PDGFRα and Flt3 with IC50 of 10 nM, 40 nM and 81 nM, respectively. Amuvatinib suppresses c-MET and c-RET. Amuvatinib is also active as a DNA repair protein Rad51 inhibitor with antineoplastic activity. Phase 2.
Trivial name | HPK 56 |
Catalog Number | S1244 |
Molecular Formula | C23H21N5O3S |
CAS# | 850879-09-3 |
Inchi | InChI=1S/C23H21N5O3S/c32-23(24-12-15-5-6-18-19(11-15)30-14-29-18)28-9-7-27(8-10-28)22-21-20(25-13-26-22)16-3-1-2-4-17(16)31-21/h1-6,11,13H,7-10,12,14H2,(H,24,32) |
Inchi Key | FOFDIMHVKGYHRU-UHFFFAOYSA-N |
SMILES | C1CN(CCN1C2=NC=NC3=C2OC4=CC=CC=C43)C(=S)NCC5=CC6=C(C=C5)OCO6 |
Size | 5mg |
Supplier Page | http://www.selleckchem.com/products/MP-470.html |
Additional Information | https://file.selleck.cn/downloads/struct/MP-470-chemical-structure-S1244.gif |